Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Synbio International, Inc.
- Market Cap
- Unavailable
- Price
- $0.0006
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 25.8K
About
Synbio International, Inc., an independent food company, develops and markets food products that combine meat and vegetable proteins. Its products include stuffed sandwiches, cheeseburgers, patties, and muffins. The company’s products offer a blend of meat, pork, turkey, chicken, or seafood, and soy proteins. Natural Harmony offers its products under the SoLean brand name. It serves customers through retailers in the United States. The company was formerly known as Natural Harmony Foods, Inc. and changed its name to Synbio International, Inc. in July 2024. Synbio International, Inc. was founded in 2001 and is headquartered in Fort Lauderdale, Florida.
Quick stats
Shares outstanding—
Computed float318.8M
Float / sharesUnknown
Key info
SectorConsumer Defensive
IndustryPackaged Foods
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001292490
Websitehttps://www.synbiointl.com
AI Summary
AI-generated1/3
Synbio (OTC: SYIN) Outlines a Two-Engine Healthcare Growth Strategy Combining Nutraceuticals and AI-Powered Mental Health Screening
Commercial launch underway through exclusive U.S. and Canada licensing deal; FacialDx NIMS™ clinical program advances toward Australian feasibility study; Company pursuing clinical funding structure designed to avoid further shareholder dilution NEW YORK, NY – TheNewswire - October 1, 2026 - Synbio International, Inc. (OTC: SYIN) (“Synbio” or the “Company”), an emerging healthcare company, provides a shareholder update from Chief Executive Officer Claudio Solitario. The Company is executing a dual-track strategy that combines a revenue-focused consumer wellness business with a potentially transformative AI-driven medical technology: NIMS™ (Non-invasive Medical Screening), a facial-analysis platform developed by FacialDx Inc. and being evaluated as an objective screening aid for mental health conditions including depression and post-traumatic stress disorder.